Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease model

Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease model

Copyright © 2018 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 191(2018) vom: 14. Juni, Seite 37-43
Auteur principal: Bahrami, Shervin (Auteur)
Autres auteurs: Gryz, Elzbieta Anna, Graversen, Jonas Heilskov, Troldborg, Anne, Stengaard Pedersen, Kristian, Laska, Magdalena Janina
Format: Article en ligne
Langue:English
Publié: 2018
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't EAE Endogenous retrovirus Immunosuppression, macrophages MS Peptide Immunosuppressive Agents Peptides Viral Envelope Proteins
Accès en ligne Volltext